Valeant Pharmaceuticals Files Investigational Drug Application For Cesamet In Cancer Chemotherapy-Induced Neuropathic ...

Valeant Pharmaceuticals International recently announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for Cesamet (CII) (nabilone) oral capsules for the treatment of cancer chemotherapy-induced neuropathic pain
From: www.drugdiscoveryonline.com